Latest Pre-exposure prophylaxis Stories
JOHANNESBURG and WASHINGTON, Nov.
NEW YORK, Sept.
VIENNA, July 19 /PRNewswire-USNewswire/ -- "This is a historic day for HIV prevention research.
RESEARCH TRIANGLE PARK, N.C., June 15 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics announced today that it has agreed to a co-promotion arrangement with Novartis Vaccines to jointly market and sell their respective post-exposure rabies products.
New research presented at International Microbicides Conference.
"The value of animal experiments for predicting the effectiveness of treatment strategies in clinical trials has remained controversial, mainly because of a recurrent failure of interventions apparently promising in animal models to translate to the clinic," say authors in a Research in Translation piece published in PLoS Medicine this week.
Women given the human immunodeficiency virus (HIV) prevention drug nevirapine to protect their fetus should not use an HIV-drug regimen that contains nevirapine for at least one year after childbirth, say researchers at the University of Alabama at Birmingham (UAB).
Systemic pre-exposure administration of antiretroviral drugs provides protection against intravenous and rectal transmission of HIV in mice with human immune systems, according to a new study published January 21, 2010 in the online journal PLoS ONE.
Funding and Support for HIV Prevention Research Must Continue NEW YORK, Dec.
AVAC Report Assesses Progress in AIDS Vaccine, Microbicide and PrEP Research and Calls for Urgent Coordination and Leadership in Advance of Upcoming Results NEW YORK, May 18 /PRNewswire-USNewswire/ -- "It's an exciting time in HIV prevention research.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.